Fortress Biotech, Inc.
Market Cap
110M
Short interest (Jul 15)
16.2%
Net Short (Jul 27 ): 0.0%
Borrow Fee
9.07%
↓ 4.3%
Available Shares
500K
↓ 44.6%
Price Chart
Company Overview
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.